- Home
- GHM vs ABSI Comparison
GHM vs ABSI Comparison
Compare GHM & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHM
- ABSI
- Stock Information
- Founded
- GHM 1936
- ABSI 2011
- Country
- GHM United States
- ABSI United States
- Employees
- GHM N/A
- ABSI N/A
- Industry
- GHM Industrial Machinery/Components
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- GHM Industrials
- ABSI Health Care
- Exchange
- GHM Nasdaq
- ABSI Nasdaq
- Market Cap
- GHM 490.8M
- ABSI 457.6M
- IPO Year
- GHM N/A
- ABSI 2021
- Fundamental
- Price
- GHM $40.78
- ABSI $2.99
- Analyst Decision
- GHM Buy
- ABSI Strong Buy
- Analyst Count
- GHM 1
- ABSI 6
- Target Price
- GHM $35.00
- ABSI $8.67
- AVG Volume (30 Days)
- GHM 72.3K
- ABSI 2.5M
- Earning Date
- GHM 02-03-2025
- ABSI 11-12-2024
- Dividend Yield
- GHM N/A
- ABSI N/A
- EPS Growth
- GHM 172.71
- ABSI N/A
- EPS
- GHM 0.71
- ABSI N/A
- Revenue
- GHM $196,402,000.00
- ABSI $4,207,000.00
- Revenue This Year
- GHM $13.21
- ABSI $7.12
- Revenue Next Year
- GHM $9.89
- ABSI $202.16
- P/E Ratio
- GHM $57.22
- ABSI N/A
- Revenue Growth
- GHM 11.88
- ABSI N/A
- 52 Week Low
- GHM $18.15
- ABSI $2.45
- 52 Week High
- GHM $46.50
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- GHM 45.26
- ABSI 43.82
- Support Level
- GHM $43.45
- ABSI $2.79
- Resistance Level
- GHM $46.50
- ABSI $4.11
- Average True Range (ATR)
- GHM 1.93
- ABSI 0.43
- MACD
- GHM -0.87
- ABSI -0.02
- Stochastic Oscillator
- GHM 17.51
- ABSI 11.15
About GHM Graham Corporation
Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.